{{Rsnum
|rsid=13397985
|Gene=SP140
|Chromosome=2
|position=230226508
|Orientation=plus
|GMAF=0.1139
|Gene_s=SP110,SP140
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 1.5 | 36.9 | 61.5
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 23.8 | 76.2
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}

[http://blog.23andme.com/2008/08/31/snpwatch-researchers-find-first-snps-linked-to-common-type-of-leukemia/ 23andMe blog] chronic lymphocytic [[leukemia]]
*[[rs13397985]] 	G 	1.41

{{GWAS Summary
|SNP=rs13397985
|PubMedID=18758461
|Condition=Chronic lymphocytic leukemia
|Gene=SP140, SP110
|Risk Allele=G
|pValue=6.00E-010
|OR=1.41
|95CI=1.26-1.57
}}

{{PharmGKB
|RSID=rs13397985
|Name_s=
|Gene_s=SP110, SP140
|Feature=
|Evidence=PubMed ID:18758461; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS Results: A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia (Initial Sample Size: 505 cases, 1,438 controls; Replication Sample Size: 1,024 cases, 1,677 controls; Risk Allele: rs13397985-G). This variant is associated with Chronic lymphocytic leukemia.
|Drugs=
|Drug Classes=
|Diseases=Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356374
}}

{{PMID Auto
|PMID=20855867
|Title=Inherited genetic susceptibility to monoclonal B-cell lymphocytosis
}}

{{PMID Auto
|PMID=19620980
|Title=Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma.
|OA=1
}}

{{PMID Auto
|PMID=20731705
|Title=Genetic susceptibility for chronic lymphocytic leukemia among Chinese in Hong Kong.
|OA=1
}}

{{PMID Auto GWAS
|PMID=22700719
|Trait=None
|Title=Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.
|RiskAllele=
|Pval=2E-7
|OR=1.3900
|ORtxt=None
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs13397985
|overall_frequency_n=13
|overall_frequency_d=128
|overall_frequency=0.101562
|n_genomes=11
|n_genomes_annotated=0
|n_haplomes=12
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{PMID Auto GWAS
  |PMID=23770605
  |Trait=Chronic lymphocytic leukemia
  |Title=Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.
  |RiskAllele=G
  |Pval=1E-22
  |OR=1.45
  |ORtxt=[NR]
  |OA=1
}}

{{PMID Auto
|PMID=23455380
|Title=Risk of genome-wide association study-identified genetic variants for non-Hodgkin lymphoma in a Chinese population.
}}

{{PMID Auto GWAS
  |PMID=24292274
  |Trait=Chronic lymphocytic leukemia
  |Title=A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.
  |RiskAllele=G
  |Pval=5E-13
  |OR=1.43
  |ORtxt=[NR]
  }}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Affy500k}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}